14
Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004 Medicare Prescription Drugs Improvement and Modernization Act of 2003: What Do Employers Think?

Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

  • Upload
    steve

  • View
    22

  • Download
    0

Embed Size (px)

DESCRIPTION

Medicare Prescription Drugs Improvement and Modernization Act of 2003: What Do Employers Think?. Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004. What The Bill Isn’t. Perfect. What The Bill Is. “The Triumph Of Experience Over Hope” Apologies to Samuel Johnson. - PowerPoint PPT Presentation

Citation preview

Page 1: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

Robert S. Galvin, MDMedicare Prescription Drug CongressFebruary 26, 2004

Medicare Prescription Drugs

Improvement and Modernization

Act of 2003:

What Do Employers Think?

Medicare Prescription Drugs

Improvement and Modernization

Act of 2003:

What Do Employers Think?

Page 2: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

2

What The Bill Isn’tWhat The Bill Isn’t

Perfect Perfect

Page 3: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

3

What The Bill IsWhat The Bill Is“The Triumph Of Experience Over Hope”

Apologies to Samuel Johnson• Government Can Act on Health Care

• Employers Included in Dialogue

• Favors Competitive / Market Approach . . . But With Safety Net

• Pushes Transparency / Quality Agenda

• Encourages Consumerism . . . Creates Possibility of New Solutions

Page 4: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

4

The Devil (And The Angel) Is In The DetailsThe Devil (And The Angel) Is In The Details

• Details of ‘Actuarial Equivalency’

• FASB Guidance

• HSA Design

• Rules for PBMs and Health Plans

Page 5: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

5

Employer OptionsEmployer Options

• Drop Retiree Coverage: Government Safety Net

• Take Employer Subsidy

• Coordinate With Medicare As Primary

Page 6: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

6

Cost = Price x UseCost = Price x Use

Why Is No One Talking About the “U” Word?Why Is No One Talking About the “U” Word?

Price Use

’99 5 10 8

’00 2 12 4

’01 5 6 3

’02 6 9 4

’03 5 4 4

Mix

Page 7: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

7

Cost and Quality Must Be IntegratedCost and Quality Must Be Integrated

Paying More Means Using Less . . . Without Regard To Quality

More Gradual Change Avoids Quality Problems

Page 8: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

8

Why Is No One Talking About the “Q” Word?Why Is No One Talking About the “Q” Word?

Use = Price Sensitivity x Compliance x Quality

(Appropriateness)

Use = Price Sensitivity x Compliance x Quality

(Appropriateness)

Risk DaysSigma = 2.75Defect = 11%

Days Where Necessary Therapy Was Lacking

118,206

Days Where Unneeded Therapy Was Provided

8,904,000

Therapy Dispoused84,000,000

Page 9: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

9

Over Utilization• Overuse• Duration• Duplication

Misuse• Drug-Drug• Drug-Disease

Under Utilization

56.1% 42.6% 1.2%

What Kind of Risk?What Kind of Risk?

Page 10: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

10

Quality Saves MoneyQuality Saves Money

Conflicts Tracked: 81,423

Changes Made : 29,864 Change Rate: 37%

Duration 40%

Drug Disease 25%

Overuse 25%

Drug Interaction 5%

Duplicate Therapy 5%

Source of Savings (Approx) by Defect

’03: $10MM Saved

’04: Send Letter to Physician and Patient

Results

Page 11: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

11

Wall Street JournalDecember 4, 2004

Page 12: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

12

A Market Approach to CostsA Market Approach to Costs“Employers believe that consumer pressure is a powerful, underutilized

lever for improving quality and efficiency. They believe that higher quality and lower cost will result if consumers spend more of their own money for

services they believe are high quality, and if providers respond by improving their performance. For this strategy to succeed, consumers will

have to be activated to seek more efficient, higher quality care and physicians will have to be rewarded for delivering it.”

Sounding BoardNEJM, September 19, 2002

Transparency

Incentives and Rewards

Focus on Quality and Efficiency

Page 13: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

13

What Policies Will Accelerate Us Getting To The Right Lower Quadrant?

Efficiency and Quality Create Value Efficiency and Quality Create Value

15 58

26

1083

611

-40%

-20%

0%

20%

40%

-150%-100%-50%0%50%100%150%

Effectiveness (Actual v. Expected Complications)

Effic

ienc

y (A

ctua

l v. E

xpec

ted

Cos

t)

Hospital B

Hospital A

Hospital G

Hospital E

Hospital F

Hospital D

Hospital C

Page 14: Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004

14

National Centers of Excellence: An ExampleNational Centers of Excellence: An Example

This material is provided on the recipient's agreement that it will only be used for the purpose of describing Uniprise's products or services to the recipient. Any other use, copying or distribution without the express written permission of Uniprise is prohibited.

31

United Resource Network

$85,886$191,591

$273,701

$90,604$15,101

$0

$50,000

$100,000

$150,000

$200,000

$250,000

$300,000

Average CaseCharges

Average Case

Payment

Less: Effective Care

Savings

Less: COEDiscount

Advantage

URN Per Case

“Traditional Health Plan Experience”

“Centers of Excellence Effect”